eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]

RxCUI: 2058981
RxNorm name: eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]
Display name: eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]
Full name: eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
PROMACTA	ELTROMBOPAG OLAMINE	Novartis Pharmaceuticals Corporation	7714a0ed-34bb-46e6-a0a5-b363908b22c2	2025-12-18	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2058981

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7714a0ed-34bb-46e6-a0a5-b363908b22c2	Promacta 12.5 MG Powder for Oral Suspension [PSN] · eltrombopag 12.5 MG Powder for Oral Suspension [Promacta] [SBD] · Promacta (as eltrombopag olamine) 12.5 MG Powder for Oral Suspension [SY]	3	31	These highlights do not include all the information needed to use PROMACTA safely and effectively. See full prescribing information for PROMACTA. PROMACTA ® (eltrombopag) tablets, for oral use PROMACTA ® (eltrombopag) for oral suspension Initial U.S. Approval: 2008	20251218